GERN:NASDAQ
Geron Corp
$1.19
arrow_upward
+1.71%(+0.020) 1D
Oct 19, 11:23:07 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$1.20
High
$1.21
Low
$1.18
Mkt. cap
764.54M
Avg. vol.
9.10M
Volume
1.29M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$1.20
High
$1.21
Low
$1.18
Mkt. cap
764.54M
Avg. vol.
9.10M
Volume
1.29M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Five analysts place USD 4.25 target on Geron stock
https://www.dars.gov.et/
·
2 weeks ago
Geron Corporation (GERN) Edges Lower to $1.20 as Shares Press Against Near-Term Support - Negative Gamma
https://www.dars.gov.et/
·
2 months ago
Geron Corporation (GERN) Drops 4.23% to $1.47 as Biotech Slides Toward Key Support - Donchian Channel
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com